nodes	percent_of_prediction	percent_of_DWPC	metapath
Vardenafil—CYP3A5—Tacrolimus—atopic dermatitis	0.139	0.238	CbGbCtD
Vardenafil—CYP3A4—Pimecrolimus—atopic dermatitis	0.0909	0.156	CbGbCtD
Vardenafil—CYP3A5—Hydrocortisone—atopic dermatitis	0.0565	0.0969	CbGbCtD
Vardenafil—CYP3A4—Tacrolimus—atopic dermatitis	0.0541	0.0928	CbGbCtD
Vardenafil—CYP3A4—Loratadine—atopic dermatitis	0.0396	0.0679	CbGbCtD
Vardenafil—CYP3A4—Methylprednisolone—atopic dermatitis	0.0362	0.0621	CbGbCtD
Vardenafil—CYP3A5—Dexamethasone—atopic dermatitis	0.0351	0.0602	CbGbCtD
Vardenafil—CYP3A4—Triamcinolone—atopic dermatitis	0.0274	0.0471	CbGbCtD
Vardenafil—CYP3A4—Betamethasone—atopic dermatitis	0.0235	0.0404	CbGbCtD
Vardenafil—CYP3A4—Prednisolone—atopic dermatitis	0.0232	0.0398	CbGbCtD
Vardenafil—CYP3A4—Hydrocortisone—atopic dermatitis	0.022	0.0378	CbGbCtD
Vardenafil—CYP3A4—Prednisone—atopic dermatitis	0.0219	0.0376	CbGbCtD
Vardenafil—CYP3A4—Dexamethasone—atopic dermatitis	0.0137	0.0235	CbGbCtD
Vardenafil—Angioedema—Hydrocortisone—atopic dermatitis	0.000294	0.000738	CcSEcCtD
Vardenafil—Back pain—Triamcinolone—atopic dermatitis	0.000294	0.000735	CcSEcCtD
Vardenafil—Malaise—Hydrocortisone—atopic dermatitis	0.000291	0.000728	CcSEcCtD
Vardenafil—Loss of consciousness—Prednisolone—atopic dermatitis	0.00029	0.000726	CcSEcCtD
Vardenafil—Vertigo—Hydrocortisone—atopic dermatitis	0.00029	0.000725	CcSEcCtD
Vardenafil—Syncope—Hydrocortisone—atopic dermatitis	0.000289	0.000724	CcSEcCtD
Vardenafil—Diarrhoea—Tacrolimus—atopic dermatitis	0.000288	0.000723	CcSEcCtD
Vardenafil—Angiopathy—Dexamethasone—atopic dermatitis	0.000287	0.000719	CcSEcCtD
Vardenafil—Angiopathy—Betamethasone—atopic dermatitis	0.000287	0.000719	CcSEcCtD
Vardenafil—Convulsion—Prednisolone—atopic dermatitis	0.000286	0.000716	CcSEcCtD
Vardenafil—Loss of consciousness—Hydrocortisone—atopic dermatitis	0.000283	0.00071	CcSEcCtD
Vardenafil—Ill-defined disorder—Triamcinolone—atopic dermatitis	0.000282	0.000705	CcSEcCtD
Vardenafil—Ill-defined disorder—Methylprednisolone—atopic dermatitis	0.000281	0.000704	CcSEcCtD
Vardenafil—Convulsion—Hydrocortisone—atopic dermatitis	0.000279	0.000699	CcSEcCtD
Vardenafil—Dizziness—Tacrolimus—atopic dermatitis	0.000279	0.000698	CcSEcCtD
Vardenafil—Discomfort—Prednisolone—atopic dermatitis	0.000278	0.000695	CcSEcCtD
Vardenafil—Angioedema—Triamcinolone—atopic dermatitis	0.000277	0.000695	CcSEcCtD
Vardenafil—Haemoglobin—Prednisone—atopic dermatitis	0.000277	0.000693	CcSEcCtD
Vardenafil—Angioedema—Methylprednisolone—atopic dermatitis	0.000277	0.000693	CcSEcCtD
Vardenafil—Haemorrhage—Prednisone—atopic dermatitis	0.000275	0.00069	CcSEcCtD
Vardenafil—Erythema—Betamethasone—atopic dermatitis	0.000275	0.00069	CcSEcCtD
Vardenafil—Erythema—Dexamethasone—atopic dermatitis	0.000275	0.00069	CcSEcCtD
Vardenafil—Myalgia—Hydrocortisone—atopic dermatitis	0.000274	0.000687	CcSEcCtD
Vardenafil—Malaise—Triamcinolone—atopic dermatitis	0.000274	0.000685	CcSEcCtD
Vardenafil—Anxiety—Hydrocortisone—atopic dermatitis	0.000273	0.000685	CcSEcCtD
Vardenafil—Malaise—Methylprednisolone—atopic dermatitis	0.000273	0.000684	CcSEcCtD
Vardenafil—Vertigo—Triamcinolone—atopic dermatitis	0.000273	0.000683	CcSEcCtD
Vardenafil—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—atopic dermatitis	0.000272	0.000683	CcSEcCtD
Vardenafil—Syncope—Triamcinolone—atopic dermatitis	0.000272	0.000682	CcSEcCtD
Vardenafil—Vertigo—Methylprednisolone—atopic dermatitis	0.000272	0.000681	CcSEcCtD
Vardenafil—Syncope—Methylprednisolone—atopic dermatitis	0.000272	0.00068	CcSEcCtD
Vardenafil—Discomfort—Hydrocortisone—atopic dermatitis	0.000271	0.000679	CcSEcCtD
Vardenafil—Connective tissue disorder—Prednisone—atopic dermatitis	0.000271	0.000678	CcSEcCtD
Vardenafil—Anaphylactic shock—Prednisolone—atopic dermatitis	0.000269	0.000675	CcSEcCtD
Vardenafil—Vomiting—Tacrolimus—atopic dermatitis	0.000268	0.000672	CcSEcCtD
Vardenafil—Loss of consciousness—Triamcinolone—atopic dermatitis	0.000267	0.000668	CcSEcCtD
Vardenafil—Loss of consciousness—Methylprednisolone—atopic dermatitis	0.000266	0.000667	CcSEcCtD
Vardenafil—Rash—Tacrolimus—atopic dermatitis	0.000266	0.000666	CcSEcCtD
Vardenafil—Dermatitis—Tacrolimus—atopic dermatitis	0.000266	0.000665	CcSEcCtD
Vardenafil—Shock—Prednisolone—atopic dermatitis	0.000265	0.000664	CcSEcCtD
Vardenafil—Headache—Tacrolimus—atopic dermatitis	0.000264	0.000662	CcSEcCtD
Vardenafil—Anaphylactic shock—Hydrocortisone—atopic dermatitis	0.000263	0.000659	CcSEcCtD
Vardenafil—Convulsion—Triamcinolone—atopic dermatitis	0.000263	0.000659	CcSEcCtD
Vardenafil—Tachycardia—Prednisolone—atopic dermatitis	0.000263	0.000658	CcSEcCtD
Vardenafil—Convulsion—Methylprednisolone—atopic dermatitis	0.000262	0.000657	CcSEcCtD
Vardenafil—Infection—Hydrocortisone—atopic dermatitis	0.000261	0.000655	CcSEcCtD
Vardenafil—Hyperhidrosis—Prednisolone—atopic dermatitis	0.00026	0.000652	CcSEcCtD
Vardenafil—Shock—Hydrocortisone—atopic dermatitis	0.000259	0.000648	CcSEcCtD
Vardenafil—Myalgia—Triamcinolone—atopic dermatitis	0.000258	0.000647	CcSEcCtD
Vardenafil—Nervous system disorder—Hydrocortisone—atopic dermatitis	0.000258	0.000646	CcSEcCtD
Vardenafil—Myalgia—Methylprednisolone—atopic dermatitis	0.000258	0.000646	CcSEcCtD
Vardenafil—Arthralgia—Methylprednisolone—atopic dermatitis	0.000258	0.000646	CcSEcCtD
Vardenafil—Eye disorder—Prednisone—atopic dermatitis	0.000257	0.000645	CcSEcCtD
Vardenafil—Anxiety—Methylprednisolone—atopic dermatitis	0.000257	0.000643	CcSEcCtD
Vardenafil—Tachycardia—Hydrocortisone—atopic dermatitis	0.000257	0.000643	CcSEcCtD
Vardenafil—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	0.000256	0.000641	CcSEcCtD
Vardenafil—Flushing—Prednisone—atopic dermatitis	0.000256	0.00064	CcSEcCtD
Vardenafil—Skin disorder—Hydrocortisone—atopic dermatitis	0.000255	0.00064	CcSEcCtD
Vardenafil—Ill-defined disorder—Dexamethasone—atopic dermatitis	0.000255	0.00064	CcSEcCtD
Vardenafil—Ill-defined disorder—Betamethasone—atopic dermatitis	0.000255	0.00064	CcSEcCtD
Vardenafil—Discomfort—Triamcinolone—atopic dermatitis	0.000255	0.000639	CcSEcCtD
Vardenafil—Discomfort—Methylprednisolone—atopic dermatitis	0.000255	0.000638	CcSEcCtD
Vardenafil—Hyperhidrosis—Hydrocortisone—atopic dermatitis	0.000254	0.000637	CcSEcCtD
Vardenafil—Dry mouth—Triamcinolone—atopic dermatitis	0.000253	0.000633	CcSEcCtD
Vardenafil—Angioedema—Betamethasone—atopic dermatitis	0.000252	0.00063	CcSEcCtD
Vardenafil—Angioedema—Dexamethasone—atopic dermatitis	0.000252	0.00063	CcSEcCtD
Vardenafil—Nausea—Tacrolimus—atopic dermatitis	0.00025	0.000627	CcSEcCtD
Vardenafil—PDE1B—Downstream signal transduction—STAT6—atopic dermatitis	0.00025	0.014	CbGpPWpGaD
Vardenafil—Angiopathy—Prednisone—atopic dermatitis	0.00025	0.000626	CcSEcCtD
Vardenafil—Immune system disorder—Prednisone—atopic dermatitis	0.000249	0.000623	CcSEcCtD
Vardenafil—Malaise—Betamethasone—atopic dermatitis	0.000248	0.000622	CcSEcCtD
Vardenafil—Malaise—Dexamethasone—atopic dermatitis	0.000248	0.000622	CcSEcCtD
Vardenafil—Anaphylactic shock—Triamcinolone—atopic dermatitis	0.000248	0.00062	CcSEcCtD
Vardenafil—Vertigo—Dexamethasone—atopic dermatitis	0.000247	0.00062	CcSEcCtD
Vardenafil—Vertigo—Betamethasone—atopic dermatitis	0.000247	0.00062	CcSEcCtD
Vardenafil—Anaphylactic shock—Methylprednisolone—atopic dermatitis	0.000247	0.000619	CcSEcCtD
Vardenafil—Syncope—Dexamethasone—atopic dermatitis	0.000247	0.000619	CcSEcCtD
Vardenafil—Syncope—Betamethasone—atopic dermatitis	0.000247	0.000619	CcSEcCtD
Vardenafil—Infection—Triamcinolone—atopic dermatitis	0.000246	0.000616	CcSEcCtD
Vardenafil—Hypotension—Hydrocortisone—atopic dermatitis	0.000246	0.000616	CcSEcCtD
Vardenafil—Infection—Methylprednisolone—atopic dermatitis	0.000246	0.000615	CcSEcCtD
Vardenafil—Shock—Triamcinolone—atopic dermatitis	0.000244	0.00061	CcSEcCtD
Vardenafil—Insomnia—Prednisolone—atopic dermatitis	0.000244	0.00061	CcSEcCtD
Vardenafil—Shock—Methylprednisolone—atopic dermatitis	0.000243	0.000609	CcSEcCtD
Vardenafil—Nervous system disorder—Methylprednisolone—atopic dermatitis	0.000242	0.000607	CcSEcCtD
Vardenafil—Loss of consciousness—Betamethasone—atopic dermatitis	0.000242	0.000606	CcSEcCtD
Vardenafil—Loss of consciousness—Dexamethasone—atopic dermatitis	0.000242	0.000606	CcSEcCtD
Vardenafil—Paraesthesia—Prednisolone—atopic dermatitis	0.000242	0.000606	CcSEcCtD
Vardenafil—Tachycardia—Triamcinolone—atopic dermatitis	0.000242	0.000605	CcSEcCtD
Vardenafil—Mental disorder—Prednisone—atopic dermatitis	0.000241	0.000604	CcSEcCtD
Vardenafil—Tachycardia—Methylprednisolone—atopic dermatitis	0.000241	0.000604	CcSEcCtD
Vardenafil—Skin disorder—Methylprednisolone—atopic dermatitis	0.00024	0.000601	CcSEcCtD
Vardenafil—Erythema—Prednisone—atopic dermatitis	0.00024	0.000601	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	0.00024	0.0006	CcSEcCtD
Vardenafil—Hyperhidrosis—Triamcinolone—atopic dermatitis	0.000239	0.0006	CcSEcCtD
Vardenafil—Hyperhidrosis—Methylprednisolone—atopic dermatitis	0.000239	0.000598	CcSEcCtD
Vardenafil—Convulsion—Dexamethasone—atopic dermatitis	0.000239	0.000598	CcSEcCtD
Vardenafil—Convulsion—Betamethasone—atopic dermatitis	0.000239	0.000598	CcSEcCtD
Vardenafil—PDE1B—G alpha (s) signalling events—NPS—atopic dermatitis	0.000238	0.0133	CbGpPWpGaD
Vardenafil—Insomnia—Hydrocortisone—atopic dermatitis	0.000238	0.000596	CcSEcCtD
Vardenafil—Paraesthesia—Hydrocortisone—atopic dermatitis	0.000236	0.000592	CcSEcCtD
Vardenafil—Myalgia—Betamethasone—atopic dermatitis	0.000234	0.000587	CcSEcCtD
Vardenafil—Myalgia—Dexamethasone—atopic dermatitis	0.000234	0.000587	CcSEcCtD
Vardenafil—Anxiety—Dexamethasone—atopic dermatitis	0.000234	0.000585	CcSEcCtD
Vardenafil—Anxiety—Betamethasone—atopic dermatitis	0.000234	0.000585	CcSEcCtD
Vardenafil—PDE5A—Hemostasis—KIF3A—atopic dermatitis	0.000232	0.013	CbGpPWpGaD
Vardenafil—PDE10A—Hemostasis—KIF3A—atopic dermatitis	0.000232	0.013	CbGpPWpGaD
Vardenafil—Discomfort—Betamethasone—atopic dermatitis	0.000232	0.00058	CcSEcCtD
Vardenafil—Discomfort—Dexamethasone—atopic dermatitis	0.000232	0.00058	CcSEcCtD
Vardenafil—Dyspepsia—Hydrocortisone—atopic dermatitis	0.000232	0.00058	CcSEcCtD
Vardenafil—Hypotension—Methylprednisolone—atopic dermatitis	0.000231	0.000578	CcSEcCtD
Vardenafil—Pain—Prednisolone—atopic dermatitis	0.00023	0.000577	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	0.000227	0.000569	CcSEcCtD
Vardenafil—PDE1B—Signaling by PDGF—STAT6—atopic dermatitis	0.000227	0.0127	CbGpPWpGaD
Vardenafil—Vision blurred—Prednisone—atopic dermatitis	0.000226	0.000566	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	0.000226	0.000565	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	0.000225	0.000564	CcSEcCtD
Vardenafil—Pain—Hydrocortisone—atopic dermatitis	0.000225	0.000563	CcSEcCtD
Vardenafil—Anaphylactic shock—Dexamethasone—atopic dermatitis	0.000225	0.000563	CcSEcCtD
Vardenafil—Anaphylactic shock—Betamethasone—atopic dermatitis	0.000225	0.000563	CcSEcCtD
Vardenafil—Insomnia—Triamcinolone—atopic dermatitis	0.000224	0.000561	CcSEcCtD
Vardenafil—Insomnia—Methylprednisolone—atopic dermatitis	0.000224	0.00056	CcSEcCtD
Vardenafil—Infection—Betamethasone—atopic dermatitis	0.000223	0.000559	CcSEcCtD
Vardenafil—Infection—Dexamethasone—atopic dermatitis	0.000223	0.000559	CcSEcCtD
Vardenafil—Ill-defined disorder—Prednisone—atopic dermatitis	0.000222	0.000557	CcSEcCtD
Vardenafil—Paraesthesia—Triamcinolone—atopic dermatitis	0.000222	0.000557	CcSEcCtD
Vardenafil—Feeling abnormal—Prednisolone—atopic dermatitis	0.000222	0.000556	CcSEcCtD
Vardenafil—Paraesthesia—Methylprednisolone—atopic dermatitis	0.000222	0.000556	CcSEcCtD
Vardenafil—Shock—Dexamethasone—atopic dermatitis	0.000221	0.000554	CcSEcCtD
Vardenafil—Shock—Betamethasone—atopic dermatitis	0.000221	0.000554	CcSEcCtD
Vardenafil—Dyspnoea—Triamcinolone—atopic dermatitis	0.000221	0.000553	CcSEcCtD
Vardenafil—Nervous system disorder—Dexamethasone—atopic dermatitis	0.00022	0.000552	CcSEcCtD
Vardenafil—Nervous system disorder—Betamethasone—atopic dermatitis	0.00022	0.000552	CcSEcCtD
Vardenafil—Tachycardia—Betamethasone—atopic dermatitis	0.000219	0.000549	CcSEcCtD
Vardenafil—Tachycardia—Dexamethasone—atopic dermatitis	0.000219	0.000549	CcSEcCtD
Vardenafil—Angioedema—Prednisone—atopic dermatitis	0.000219	0.000549	CcSEcCtD
Vardenafil—Dyspepsia—Triamcinolone—atopic dermatitis	0.000218	0.000546	CcSEcCtD
Vardenafil—Dyspepsia—Methylprednisolone—atopic dermatitis	0.000218	0.000545	CcSEcCtD
Vardenafil—Hyperhidrosis—Dexamethasone—atopic dermatitis	0.000217	0.000544	CcSEcCtD
Vardenafil—Hyperhidrosis—Betamethasone—atopic dermatitis	0.000217	0.000544	CcSEcCtD
Vardenafil—Feeling abnormal—Hydrocortisone—atopic dermatitis	0.000217	0.000543	CcSEcCtD
Vardenafil—Malaise—Prednisone—atopic dermatitis	0.000216	0.000542	CcSEcCtD
Vardenafil—Vertigo—Prednisone—atopic dermatitis	0.000215	0.00054	CcSEcCtD
Vardenafil—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	0.000215	0.000539	CcSEcCtD
Vardenafil—Syncope—Prednisone—atopic dermatitis	0.000215	0.000539	CcSEcCtD
Vardenafil—Pain—Triamcinolone—atopic dermatitis	0.000212	0.000531	CcSEcCtD
Vardenafil—Loss of consciousness—Prednisone—atopic dermatitis	0.000211	0.000528	CcSEcCtD
Vardenafil—Hypotension—Betamethasone—atopic dermatitis	0.00021	0.000526	CcSEcCtD
Vardenafil—Hypotension—Dexamethasone—atopic dermatitis	0.00021	0.000526	CcSEcCtD
Vardenafil—PDE11A—Hemostasis—SELE—atopic dermatitis	0.00021	0.0118	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—CCL22—atopic dermatitis	0.00021	0.0118	CbGpPWpGaD
Vardenafil—Abdominal pain—Hydrocortisone—atopic dermatitis	0.000208	0.000521	CcSEcCtD
Vardenafil—Convulsion—Prednisone—atopic dermatitis	0.000208	0.00052	CcSEcCtD
Vardenafil—PDE11A—GPCR downstream signaling—CCL27—atopic dermatitis	0.000206	0.0115	CbGpPWpGaD
Vardenafil—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	0.000205	0.000513	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	0.000205	0.000513	CcSEcCtD
Vardenafil—Arthralgia—Prednisone—atopic dermatitis	0.000204	0.000511	CcSEcCtD
Vardenafil—Myalgia—Prednisone—atopic dermatitis	0.000204	0.000511	CcSEcCtD
Vardenafil—Feeling abnormal—Triamcinolone—atopic dermatitis	0.000204	0.000511	CcSEcCtD
Vardenafil—Feeling abnormal—Methylprednisolone—atopic dermatitis	0.000204	0.00051	CcSEcCtD
Vardenafil—Anxiety—Prednisone—atopic dermatitis	0.000203	0.00051	CcSEcCtD
Vardenafil—Insomnia—Dexamethasone—atopic dermatitis	0.000203	0.000509	CcSEcCtD
Vardenafil—Insomnia—Betamethasone—atopic dermatitis	0.000203	0.000509	CcSEcCtD
Vardenafil—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	0.000203	0.000508	CcSEcCtD
Vardenafil—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	0.000202	0.000506	CcSEcCtD
Vardenafil—Paraesthesia—Betamethasone—atopic dermatitis	0.000202	0.000505	CcSEcCtD
Vardenafil—Paraesthesia—Dexamethasone—atopic dermatitis	0.000202	0.000505	CcSEcCtD
Vardenafil—Discomfort—Prednisone—atopic dermatitis	0.000202	0.000505	CcSEcCtD
Vardenafil—Hypersensitivity—Prednisolone—atopic dermatitis	0.000198	0.000497	CcSEcCtD
Vardenafil—Dyspepsia—Betamethasone—atopic dermatitis	0.000198	0.000495	CcSEcCtD
Vardenafil—Dyspepsia—Dexamethasone—atopic dermatitis	0.000198	0.000495	CcSEcCtD
Vardenafil—Anaphylactic shock—Prednisone—atopic dermatitis	0.000196	0.00049	CcSEcCtD
Vardenafil—Abdominal pain—Methylprednisolone—atopic dermatitis	0.000195	0.000489	CcSEcCtD
Vardenafil—Infection—Prednisone—atopic dermatitis	0.000194	0.000487	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Betamethasone—atopic dermatitis	0.000194	0.000486	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	0.000194	0.000486	CcSEcCtD
Vardenafil—Hypersensitivity—Hydrocortisone—atopic dermatitis	0.000194	0.000485	CcSEcCtD
Vardenafil—Shock—Prednisone—atopic dermatitis	0.000193	0.000482	CcSEcCtD
Vardenafil—Pain—Dexamethasone—atopic dermatitis	0.000192	0.000481	CcSEcCtD
Vardenafil—Pain—Betamethasone—atopic dermatitis	0.000192	0.000481	CcSEcCtD
Vardenafil—Nervous system disorder—Prednisone—atopic dermatitis	0.000192	0.000481	CcSEcCtD
Vardenafil—Tachycardia—Prednisone—atopic dermatitis	0.000191	0.000478	CcSEcCtD
Vardenafil—Skin disorder—Prednisone—atopic dermatitis	0.00019	0.000476	CcSEcCtD
Vardenafil—Hyperhidrosis—Prednisone—atopic dermatitis	0.000189	0.000474	CcSEcCtD
Vardenafil—Asthenia—Hydrocortisone—atopic dermatitis	0.000189	0.000473	CcSEcCtD
Vardenafil—PDE10A—Hemostasis—SELE—atopic dermatitis	0.000187	0.0105	CbGpPWpGaD
Vardenafil—PDE5A—Hemostasis—SELE—atopic dermatitis	0.000187	0.0105	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—CCL27—atopic dermatitis	0.000187	0.0105	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—CCL22—atopic dermatitis	0.000187	0.0105	CbGpPWpGaD
Vardenafil—Pruritus—Hydrocortisone—atopic dermatitis	0.000186	0.000466	CcSEcCtD
Vardenafil—Feeling abnormal—Betamethasone—atopic dermatitis	0.000185	0.000464	CcSEcCtD
Vardenafil—Feeling abnormal—Dexamethasone—atopic dermatitis	0.000185	0.000464	CcSEcCtD
Vardenafil—Gastrointestinal pain—Dexamethasone—atopic dermatitis	0.000184	0.00046	CcSEcCtD
Vardenafil—Gastrointestinal pain—Betamethasone—atopic dermatitis	0.000184	0.00046	CcSEcCtD
Vardenafil—PDE10A—GPCR downstream signaling—CCL27—atopic dermatitis	0.000183	0.0103	CbGpPWpGaD
Vardenafil—Hypersensitivity—Triamcinolone—atopic dermatitis	0.000182	0.000457	CcSEcCtD
Vardenafil—Hypersensitivity—Methylprednisolone—atopic dermatitis	0.000182	0.000456	CcSEcCtD
Vardenafil—Diarrhoea—Hydrocortisone—atopic dermatitis	0.00018	0.000451	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Prednisone—atopic dermatitis	0.000178	0.000447	CcSEcCtD
Vardenafil—Dizziness—Prednisolone—atopic dermatitis	0.000178	0.000446	CcSEcCtD
Vardenafil—Asthenia—Triamcinolone—atopic dermatitis	0.000178	0.000445	CcSEcCtD
Vardenafil—Abdominal pain—Betamethasone—atopic dermatitis	0.000178	0.000445	CcSEcCtD
Vardenafil—Abdominal pain—Dexamethasone—atopic dermatitis	0.000178	0.000445	CcSEcCtD
Vardenafil—Asthenia—Methylprednisolone—atopic dermatitis	0.000177	0.000444	CcSEcCtD
Vardenafil—Insomnia—Prednisone—atopic dermatitis	0.000177	0.000443	CcSEcCtD
Vardenafil—Paraesthesia—Prednisone—atopic dermatitis	0.000176	0.00044	CcSEcCtD
Vardenafil—Pruritus—Triamcinolone—atopic dermatitis	0.000175	0.000439	CcSEcCtD
Vardenafil—Pruritus—Methylprednisolone—atopic dermatitis	0.000175	0.000438	CcSEcCtD
Vardenafil—Dizziness—Hydrocortisone—atopic dermatitis	0.000174	0.000436	CcSEcCtD
Vardenafil—Dyspepsia—Prednisone—atopic dermatitis	0.000172	0.000432	CcSEcCtD
Vardenafil—Rash—Prednisolone—atopic dermatitis	0.00017	0.000425	CcSEcCtD
Vardenafil—Dermatitis—Prednisolone—atopic dermatitis	0.00017	0.000425	CcSEcCtD
Vardenafil—Diarrhoea—Methylprednisolone—atopic dermatitis	0.000169	0.000424	CcSEcCtD
Vardenafil—Headache—Prednisolone—atopic dermatitis	0.000169	0.000423	CcSEcCtD
Vardenafil—PDE11A—Signaling by GPCR—CCL17—atopic dermatitis	0.000168	0.0094	CbGpPWpGaD
Vardenafil—Vomiting—Hydrocortisone—atopic dermatitis	0.000167	0.000419	CcSEcCtD
Vardenafil—PDE10A—Signaling by GPCR—CCL27—atopic dermatitis	0.000167	0.00934	CbGpPWpGaD
Vardenafil—Rash—Hydrocortisone—atopic dermatitis	0.000166	0.000415	CcSEcCtD
Vardenafil—Dermatitis—Hydrocortisone—atopic dermatitis	0.000166	0.000415	CcSEcCtD
Vardenafil—Headache—Hydrocortisone—atopic dermatitis	0.000165	0.000413	CcSEcCtD
Vardenafil—Dizziness—Triamcinolone—atopic dermatitis	0.000164	0.00041	CcSEcCtD
Vardenafil—Dizziness—Methylprednisolone—atopic dermatitis	0.000163	0.000409	CcSEcCtD
Vardenafil—Feeling abnormal—Prednisone—atopic dermatitis	0.000161	0.000404	CcSEcCtD
Vardenafil—Asthenia—Betamethasone—atopic dermatitis	0.000161	0.000404	CcSEcCtD
Vardenafil—Asthenia—Dexamethasone—atopic dermatitis	0.000161	0.000404	CcSEcCtD
Vardenafil—Gastrointestinal pain—Prednisone—atopic dermatitis	0.00016	0.000401	CcSEcCtD
Vardenafil—Nausea—Prednisolone—atopic dermatitis	0.00016	0.000401	CcSEcCtD
Vardenafil—PDE1B—Innate Immune System—FCER1A—atopic dermatitis	0.00016	0.00896	CbGpPWpGaD
Vardenafil—PDE11A—Hemostasis—IL5—atopic dermatitis	0.000159	0.00892	CbGpPWpGaD
Vardenafil—Pruritus—Dexamethasone—atopic dermatitis	0.000159	0.000398	CcSEcCtD
Vardenafil—Pruritus—Betamethasone—atopic dermatitis	0.000159	0.000398	CcSEcCtD
Vardenafil—Vomiting—Triamcinolone—atopic dermatitis	0.000157	0.000394	CcSEcCtD
Vardenafil—Vomiting—Methylprednisolone—atopic dermatitis	0.000157	0.000394	CcSEcCtD
Vardenafil—Nausea—Hydrocortisone—atopic dermatitis	0.000156	0.000391	CcSEcCtD
Vardenafil—Rash—Triamcinolone—atopic dermatitis	0.000156	0.000391	CcSEcCtD
Vardenafil—Dermatitis—Triamcinolone—atopic dermatitis	0.000156	0.000391	CcSEcCtD
Vardenafil—Rash—Methylprednisolone—atopic dermatitis	0.000156	0.00039	CcSEcCtD
Vardenafil—Dermatitis—Methylprednisolone—atopic dermatitis	0.000156	0.00039	CcSEcCtD
Vardenafil—Headache—Triamcinolone—atopic dermatitis	0.000155	0.000389	CcSEcCtD
Vardenafil—Headache—Methylprednisolone—atopic dermatitis	0.000155	0.000388	CcSEcCtD
Vardenafil—Abdominal pain—Prednisone—atopic dermatitis	0.000155	0.000388	CcSEcCtD
Vardenafil—Diarrhoea—Betamethasone—atopic dermatitis	0.000154	0.000385	CcSEcCtD
Vardenafil—Diarrhoea—Dexamethasone—atopic dermatitis	0.000154	0.000385	CcSEcCtD
Vardenafil—PDE1B—Immune System—CTSE—atopic dermatitis	0.000151	0.00845	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—CCL17—atopic dermatitis	0.000149	0.00838	CbGpPWpGaD
Vardenafil—Dizziness—Betamethasone—atopic dermatitis	0.000149	0.000372	CcSEcCtD
Vardenafil—Dizziness—Dexamethasone—atopic dermatitis	0.000149	0.000372	CcSEcCtD
Vardenafil—PDE1B—Innate Immune System—MS4A2—atopic dermatitis	0.000149	0.00833	CbGpPWpGaD
Vardenafil—Nausea—Triamcinolone—atopic dermatitis	0.000147	0.000368	CcSEcCtD
Vardenafil—Nausea—Methylprednisolone—atopic dermatitis	0.000147	0.000368	CcSEcCtD
Vardenafil—Hypersensitivity—Prednisone—atopic dermatitis	0.000144	0.000361	CcSEcCtD
Vardenafil—Vomiting—Betamethasone—atopic dermatitis	0.000143	0.000358	CcSEcCtD
Vardenafil—Vomiting—Dexamethasone—atopic dermatitis	0.000143	0.000358	CcSEcCtD
Vardenafil—PDE5A—Hemostasis—IL5—atopic dermatitis	0.000142	0.00795	CbGpPWpGaD
Vardenafil—PDE10A—Hemostasis—IL5—atopic dermatitis	0.000142	0.00795	CbGpPWpGaD
Vardenafil—Rash—Betamethasone—atopic dermatitis	0.000142	0.000355	CcSEcCtD
Vardenafil—Rash—Dexamethasone—atopic dermatitis	0.000142	0.000355	CcSEcCtD
Vardenafil—Dermatitis—Dexamethasone—atopic dermatitis	0.000142	0.000355	CcSEcCtD
Vardenafil—Dermatitis—Betamethasone—atopic dermatitis	0.000142	0.000355	CcSEcCtD
Vardenafil—Headache—Dexamethasone—atopic dermatitis	0.000141	0.000353	CcSEcCtD
Vardenafil—Headache—Betamethasone—atopic dermatitis	0.000141	0.000353	CcSEcCtD
Vardenafil—Asthenia—Prednisone—atopic dermatitis	0.00014	0.000352	CcSEcCtD
Vardenafil—Pruritus—Prednisone—atopic dermatitis	0.000138	0.000347	CcSEcCtD
Vardenafil—PDE6G—Disease—GLB1—atopic dermatitis	0.000138	0.00771	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—CCL11—atopic dermatitis	0.000135	0.00758	CbGpPWpGaD
Vardenafil—Diarrhoea—Prednisone—atopic dermatitis	0.000134	0.000335	CcSEcCtD
Vardenafil—Nausea—Betamethasone—atopic dermatitis	0.000133	0.000334	CcSEcCtD
Vardenafil—Nausea—Dexamethasone—atopic dermatitis	0.000133	0.000334	CcSEcCtD
Vardenafil—PDE11A—Signaling Pathways—FCER2—atopic dermatitis	0.000133	0.00747	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—DEFB1—atopic dermatitis	0.000132	0.00743	CbGpPWpGaD
Vardenafil—Dizziness—Prednisone—atopic dermatitis	0.000129	0.000324	CcSEcCtD
Vardenafil—Vomiting—Prednisone—atopic dermatitis	0.000124	0.000312	CcSEcCtD
Vardenafil—PDE11A—Signaling Pathways—CCL22—atopic dermatitis	0.000124	0.00695	CbGpPWpGaD
Vardenafil—Rash—Prednisone—atopic dermatitis	0.000123	0.000309	CcSEcCtD
Vardenafil—Dermatitis—Prednisone—atopic dermatitis	0.000123	0.000309	CcSEcCtD
Vardenafil—Headache—Prednisone—atopic dermatitis	0.000123	0.000307	CcSEcCtD
Vardenafil—PDE6G—Signaling Pathways—FCER2—atopic dermatitis	0.000122	0.00683	CbGpPWpGaD
Vardenafil—PDE11A—GPCR downstream signaling—CCR3—atopic dermatitis	0.000121	0.0068	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—CCL11—atopic dermatitis	0.00012	0.00675	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—FCER2—atopic dermatitis	0.000119	0.00666	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—KIF3A—atopic dermatitis	0.000118	0.0066	CbGpPWpGaD
Vardenafil—Nausea—Prednisone—atopic dermatitis	0.000116	0.000291	CcSEcCtD
Vardenafil—PDE6G—Signaling Pathways—CCL22—atopic dermatitis	0.000113	0.00635	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—CCL27—atopic dermatitis	0.00011	0.00619	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—CCL22—atopic dermatitis	0.00011	0.00619	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—CCR3—atopic dermatitis	0.00011	0.00618	CbGpPWpGaD
Vardenafil—PDE11A—GPCR downstream signaling—NPS—atopic dermatitis	0.000108	0.00606	CbGpPWpGaD
Vardenafil—PDE11A—GPCR downstream signaling—TAC1—atopic dermatitis	0.000108	0.00606	CbGpPWpGaD
Vardenafil—PDE10A—GPCR downstream signaling—CCR3—atopic dermatitis	0.000108	0.00606	CbGpPWpGaD
Vardenafil—PDE11A—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000106	0.00595	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—CCL27—atopic dermatitis	0.000101	0.00566	CbGpPWpGaD
Vardenafil—PDE11A—GPCR downstream signaling—IL5—atopic dermatitis	0.000101	0.00564	CbGpPWpGaD
Vardenafil—PDE1B—NGF signalling via TRKA from the plasma membrane—NGF—atopic dermatitis	0.0001	0.00562	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—CCL17—atopic dermatitis	9.9e-05	0.00555	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—CCL27—atopic dermatitis	9.84e-05	0.00552	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—NPS—atopic dermatitis	9.82e-05	0.00551	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—TAC1—atopic dermatitis	9.82e-05	0.00551	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—CCR3—atopic dermatitis	9.82e-05	0.00551	CbGpPWpGaD
Vardenafil—PDE10A—GPCR downstream signaling—TAC1—atopic dermatitis	9.64e-05	0.0054	CbGpPWpGaD
Vardenafil—PDE10A—GPCR downstream signaling—NPS—atopic dermatitis	9.64e-05	0.0054	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—CXCR3—atopic dermatitis	9.63e-05	0.0054	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—SELE—atopic dermatitis	9.48e-05	0.00532	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—CCL22—atopic dermatitis	9.47e-05	0.00531	CbGpPWpGaD
Vardenafil—PDE10A—GPCR downstream signaling—CXCR3—atopic dermatitis	9.45e-05	0.0053	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—FCER1A—atopic dermatitis	9.31e-05	0.00522	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—CCL27—atopic dermatitis	9.3e-05	0.00521	CbGpPWpGaD
Vardenafil—PDE6G—Disease—SLC11A1—atopic dermatitis	9.22e-05	0.00517	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—IL5—atopic dermatitis	9.13e-05	0.00512	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—CCL17—atopic dermatitis	9.06e-05	0.00508	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—STAT6—atopic dermatitis	9e-05	0.00505	CbGpPWpGaD
Vardenafil—PDE10A—GPCR downstream signaling—IL5—atopic dermatitis	8.96e-05	0.00502	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—KIF3A—atopic dermatitis	8.83e-05	0.00495	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—CCL17—atopic dermatitis	8.83e-05	0.00495	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—CARD11—atopic dermatitis	8.76e-05	0.00491	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—TAC1—atopic dermatitis	8.75e-05	0.00491	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—NPS—atopic dermatitis	8.75e-05	0.00491	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—MS4A2—atopic dermatitis	8.65e-05	0.00485	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—CXCR3—atopic dermatitis	8.58e-05	0.00481	CbGpPWpGaD
Vardenafil—PDE11A—GPCR downstream signaling—CXCL10—atopic dermatitis	8.57e-05	0.00481	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—CCL27—atopic dermatitis	8.44e-05	0.00473	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—IL5—atopic dermatitis	8.14e-05	0.00456	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—KIF3A—atopic dermatitis	8.07e-05	0.00453	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—CMA1—atopic dermatitis	7.98e-05	0.00448	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—CCL11—atopic dermatitis	7.98e-05	0.00448	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—KIF3A—atopic dermatitis	7.87e-05	0.00441	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—CXCL10—atopic dermatitis	7.78e-05	0.00436	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—DEFB1—atopic dermatitis	7.71e-05	0.00433	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by NGF—NGF—atopic dermatitis	7.71e-05	0.00432	CbGpPWpGaD
Vardenafil—PDE10A—GPCR downstream signaling—CXCL10—atopic dermatitis	7.64e-05	0.00428	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—CCL17—atopic dermatitis	7.57e-05	0.00425	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—STAT6—atopic dermatitis	7.51e-05	0.00421	CbGpPWpGaD
Vardenafil—PDE11A—GPCR downstream signaling—CCL5—atopic dermatitis	7.38e-05	0.00414	CbGpPWpGaD
Vardenafil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	7.31e-05	0.0041	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—CCL11—atopic dermatitis	7.3e-05	0.00409	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—CMA1—atopic dermatitis	7.3e-05	0.00409	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—IL5—atopic dermatitis	7.18e-05	0.00403	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—CCL11—atopic dermatitis	7.11e-05	0.00399	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—CMA1—atopic dermatitis	7.11e-05	0.00399	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—CXCL10—atopic dermatitis	6.94e-05	0.00389	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—STAT6—atopic dermatitis	6.86e-05	0.00385	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—CASP1—atopic dermatitis	6.82e-05	0.00383	CbGpPWpGaD
Vardenafil—PDE1B—Disease—GLB1—atopic dermatitis	6.79e-05	0.00381	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—CCL5—atopic dermatitis	6.7e-05	0.00376	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—STAT6—atopic dermatitis	6.69e-05	0.00375	CbGpPWpGaD
Vardenafil—PDE11A—GPCR downstream signaling—CCR5—atopic dermatitis	6.65e-05	0.00373	CbGpPWpGaD
Vardenafil—PDE10A—GPCR downstream signaling—CCL5—atopic dermatitis	6.58e-05	0.00369	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—CCR3—atopic dermatitis	6.51e-05	0.00365	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by NGF—NFKBIA—atopic dermatitis	6.36e-05	0.00357	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—TLR2—atopic dermatitis	6.17e-05	0.00346	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—KIF3A—atopic dermatitis	6.17e-05	0.00346	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—CCL11—atopic dermatitis	6.1e-05	0.00342	CbGpPWpGaD
Vardenafil—PDE11A—Hemostasis—IL2—atopic dermatitis	6.08e-05	0.00341	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—CCR5—atopic dermatitis	6.04e-05	0.00338	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—FCER2—atopic dermatitis	6.02e-05	0.00338	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—CCL5—atopic dermatitis	5.97e-05	0.00335	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—CCR3—atopic dermatitis	5.95e-05	0.00334	CbGpPWpGaD
Vardenafil—PDE10A—GPCR downstream signaling—CCR5—atopic dermatitis	5.92e-05	0.00332	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—TAC1—atopic dermatitis	5.8e-05	0.00325	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—CCR3—atopic dermatitis	5.8e-05	0.00325	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—NPS—atopic dermatitis	5.8e-05	0.00325	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—CXCR3—atopic dermatitis	5.69e-05	0.00319	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CCL22—atopic dermatitis	5.6e-05	0.00314	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—CCR3—atopic dermatitis	5.48e-05	0.00307	CbGpPWpGaD
Vardenafil—PDE10A—Hemostasis—IL2—atopic dermatitis	5.42e-05	0.00304	CbGpPWpGaD
Vardenafil—PDE5A—Hemostasis—IL2—atopic dermatitis	5.42e-05	0.00304	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—IL5—atopic dermatitis	5.39e-05	0.00302	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—CCR5—atopic dermatitis	5.38e-05	0.00302	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—TAC1—atopic dermatitis	5.3e-05	0.00297	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—NPS—atopic dermatitis	5.3e-05	0.00297	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—STAT6—atopic dermatitis	5.24e-05	0.00294	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—CXCR3—atopic dermatitis	5.2e-05	0.00292	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—TAC1—atopic dermatitis	5.17e-05	0.0029	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—NPS—atopic dermatitis	5.17e-05	0.0029	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—CARD11—atopic dermatitis	5.1e-05	0.00286	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—CXCR3—atopic dermatitis	5.07e-05	0.00284	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CCL27—atopic dermatitis	4.99e-05	0.0028	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—CCR3—atopic dermatitis	4.98e-05	0.00279	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—IL5—atopic dermatitis	4.93e-05	0.00277	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—TAC1—atopic dermatitis	4.88e-05	0.00274	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—NPS—atopic dermatitis	4.88e-05	0.00274	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—IL5—atopic dermatitis	4.81e-05	0.0027	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—CXCR3—atopic dermatitis	4.79e-05	0.00269	CbGpPWpGaD
Vardenafil—PDE6G—Disease—CCR5—atopic dermatitis	4.66e-05	0.00261	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—CXCL10—atopic dermatitis	4.6e-05	0.00258	CbGpPWpGaD
Vardenafil—PDE1B—Disease—SLC11A1—atopic dermatitis	4.55e-05	0.00255	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—IL5—atopic dermatitis	4.54e-05	0.00255	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CCL17—atopic dermatitis	4.47e-05	0.00251	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—NPS—atopic dermatitis	4.44e-05	0.00249	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—TAC1—atopic dermatitis	4.44e-05	0.00249	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—CXCR3—atopic dermatitis	4.35e-05	0.00244	CbGpPWpGaD
Vardenafil—PDE1B—Downstream signaling of activated FGFR—IL6—atopic dermatitis	4.29e-05	0.00241	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—CXCL10—atopic dermatitis	4.21e-05	0.00236	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—IL5—atopic dermatitis	4.12e-05	0.00231	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—CXCL10—atopic dermatitis	4.1e-05	0.0023	CbGpPWpGaD
Vardenafil—PDE1B—Downstream signal transduction—IL6—atopic dermatitis	4.03e-05	0.00226	CbGpPWpGaD
Vardenafil—PDE11A—GPCR downstream signaling—CXCL8—atopic dermatitis	4.02e-05	0.00225	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by FGFR—IL6—atopic dermatitis	4.01e-05	0.00225	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by ERBB2—IL6—atopic dermatitis	3.99e-05	0.00224	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by NGF—MAPK8—atopic dermatitis	3.99e-05	0.00224	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—KIF3A—atopic dermatitis	3.99e-05	0.00224	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—CASP1—atopic dermatitis	3.97e-05	0.00223	CbGpPWpGaD
Vardenafil—PDE1B—DAP12 signaling—IL6—atopic dermatitis	3.97e-05	0.00223	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—CCL5—atopic dermatitis	3.96e-05	0.00222	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—CXCL10—atopic dermatitis	3.87e-05	0.00217	CbGpPWpGaD
Vardenafil—PDE11A—GPCR downstream signaling—IL2—atopic dermatitis	3.84e-05	0.00215	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—IL5—atopic dermatitis	3.77e-05	0.00211	CbGpPWpGaD
Vardenafil—PDE1B—DAP12 interactions—IL6—atopic dermatitis	3.74e-05	0.0021	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by FGFR in disease—IL6—atopic dermatitis	3.74e-05	0.0021	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by EGFR—IL6—atopic dermatitis	3.7e-05	0.00208	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by EGFR in Cancer—IL6—atopic dermatitis	3.67e-05	0.00206	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—NGF—atopic dermatitis	3.67e-05	0.00206	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by PDGF—IL6—atopic dermatitis	3.66e-05	0.00205	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—CXCL8—atopic dermatitis	3.65e-05	0.00205	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—NFKBIA—atopic dermatitis	3.63e-05	0.00203	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—CCL5—atopic dermatitis	3.62e-05	0.00203	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CMA1—atopic dermatitis	3.61e-05	0.00202	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CCL11—atopic dermatitis	3.61e-05	0.00202	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—TLR2—atopic dermatitis	3.59e-05	0.00202	CbGpPWpGaD
Vardenafil—PDE10A—GPCR downstream signaling—CXCL8—atopic dermatitis	3.58e-05	0.00201	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—CCR5—atopic dermatitis	3.57e-05	0.002	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—CCL5—atopic dermatitis	3.53e-05	0.00198	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—CXCL10—atopic dermatitis	3.52e-05	0.00197	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—IL2—atopic dermatitis	3.49e-05	0.00196	CbGpPWpGaD
Vardenafil—PDE10A—GPCR downstream signaling—IL2—atopic dermatitis	3.42e-05	0.00192	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—STAT6—atopic dermatitis	3.39e-05	0.0019	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—CD79A—atopic dermatitis	3.38e-05	0.00189	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—NGF—atopic dermatitis	3.35e-05	0.00188	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—CCL5—atopic dermatitis	3.33e-05	0.00187	CbGpPWpGaD
Vardenafil—PDE1B—NGF signalling via TRKA from the plasma membrane—IL6—atopic dermatitis	3.31e-05	0.00186	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—CASP8—atopic dermatitis	3.27e-05	0.00183	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—NGF—atopic dermatitis	3.27e-05	0.00183	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—CCR5—atopic dermatitis	3.26e-05	0.00183	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—CXCL8—atopic dermatitis	3.25e-05	0.00182	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—CCR5—atopic dermatitis	3.18e-05	0.00178	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—IL2—atopic dermatitis	3.11e-05	0.00174	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—CCL5—atopic dermatitis	3.03e-05	0.0017	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—NFKBIA—atopic dermatitis	3.02e-05	0.0017	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—CCR5—atopic dermatitis	3e-05	0.00168	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CCR3—atopic dermatitis	2.94e-05	0.00165	CbGpPWpGaD
Vardenafil—PDE6G—Disease—CD4—atopic dermatitis	2.92e-05	0.00164	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—IL18—atopic dermatitis	2.77e-05	0.00155	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—NFKBIA—atopic dermatitis	2.76e-05	0.00155	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—IL2—atopic dermatitis	2.74e-05	0.00154	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—CCR5—atopic dermatitis	2.73e-05	0.00153	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—CD8A—atopic dermatitis	2.72e-05	0.00153	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—NFKBIA—atopic dermatitis	2.69e-05	0.00151	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—CD4—atopic dermatitis	2.69e-05	0.00151	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—TAC1—atopic dermatitis	2.62e-05	0.00147	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—NPS—atopic dermatitis	2.62e-05	0.00147	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CXCR3—atopic dermatitis	2.57e-05	0.00144	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by NGF—IL6—atopic dermatitis	2.55e-05	0.00143	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—IL5—atopic dermatitis	2.44e-05	0.00137	CbGpPWpGaD
Vardenafil—PDE1B—Disease—CCR5—atopic dermatitis	2.3e-05	0.00129	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—MAPK8—atopic dermatitis	2.27e-05	0.00128	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—GLB1—atopic dermatitis	2.27e-05	0.00127	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—ADSL—atopic dermatitis	2.17e-05	0.00122	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—CXCL8—atopic dermatitis	2.16e-05	0.00121	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—NFKBIA—atopic dermatitis	2.11e-05	0.00118	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CXCL10—atopic dermatitis	2.08e-05	0.00116	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—IL2—atopic dermatitis	2.06e-05	0.00116	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—IL6—atopic dermatitis	2.05e-05	0.00115	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—CXCL8—atopic dermatitis	1.97e-05	0.00111	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—CXCL8—atopic dermatitis	1.92e-05	0.00108	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—CASP8—atopic dermatitis	1.9e-05	0.00107	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—MAPK8—atopic dermatitis	1.9e-05	0.00106	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—IL2—atopic dermatitis	1.88e-05	0.00106	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—IL2—atopic dermatitis	1.84e-05	0.00103	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—IL6—atopic dermatitis	1.83e-05	0.00102	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—CXCL8—atopic dermatitis	1.82e-05	0.00102	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CCL5—atopic dermatitis	1.79e-05	0.001	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—IL2—atopic dermatitis	1.73e-05	0.000973	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—MAPK8—atopic dermatitis	1.73e-05	0.000973	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—MAPK8—atopic dermatitis	1.69e-05	0.000948	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—NGF—atopic dermatitis	1.66e-05	0.000928	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—CXCL8—atopic dermatitis	1.65e-05	0.000924	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—IFNG—atopic dermatitis	1.62e-05	0.000908	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CCR5—atopic dermatitis	1.61e-05	0.000903	CbGpPWpGaD
Vardenafil—PDE6G—Disease—IL6—atopic dermatitis	1.58e-05	0.000887	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—IL2—atopic dermatitis	1.58e-05	0.000883	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—CD4—atopic dermatitis	1.56e-05	0.000877	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—IL6—atopic dermatitis	1.45e-05	0.000815	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—IL1B—atopic dermatitis	1.44e-05	0.00081	CbGpPWpGaD
Vardenafil—PDE1B—Disease—CD4—atopic dermatitis	1.44e-05	0.00081	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—IL2—atopic dermatitis	1.44e-05	0.000807	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—NFKBIA—atopic dermatitis	1.37e-05	0.000766	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—MAPK8—atopic dermatitis	1.32e-05	0.000743	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—IL6—atopic dermatitis	1.21e-05	0.000679	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—IL6—atopic dermatitis	1.11e-05	0.000621	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—IL6—atopic dermatitis	1.08e-05	0.000605	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GLB1—atopic dermatitis	1.05e-05	0.000591	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ADSL—atopic dermatitis	1.01e-05	0.000566	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CXCL8—atopic dermatitis	9.74e-06	0.000546	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—IL2—atopic dermatitis	9.31e-06	0.000522	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—IL6—atopic dermatitis	9.26e-06	0.000519	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—MAPK8—atopic dermatitis	8.57e-06	0.00048	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—IL6—atopic dermatitis	8.46e-06	0.000474	CbGpPWpGaD
Vardenafil—PDE1B—Disease—IL6—atopic dermatitis	7.81e-06	0.000438	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PPARA—atopic dermatitis	7.35e-06	0.000412	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—IL6—atopic dermatitis	5.47e-06	0.000307	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PPARA—atopic dermatitis	3.42e-06	0.000192	CbGpPWpGaD
